235 related articles for article (PubMed ID: 26041965)
1. Encephalopathy in Wilson disease: copper toxicity or liver failure?
Ferenci P; Litwin T; Seniow J; Czlonkowska A
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S88-95. PubMed ID: 26041965
[TBL] [Abstract][Full Text] [Related]
2. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
3. The role of functional magnetic resonance imaging of the brain in the evaluation of hepatic encephalopathy in cirrhotic patients.
Abdelhamid MAM; Abdelsameea E; Korayem EM; Alwarraky MS; Omar HM
Clin Exp Hepatol; 2022 Dec; 8(4):321-329. PubMed ID: 36683873
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in 37 newly diagnosed Wilson's disease patients assessed by magnetic resonance spectroscopy.
Tarnacka B; Szeszkowski W; Gołebiowski M; Członkowska A
Parkinsonism Relat Disord; 2009 Sep; 15(8):582-6. PubMed ID: 19346156
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging and spectroscopy in hepatic encephalopathy.
Gupta RK; Dhiman RK
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S45-9. PubMed ID: 15025255
[TBL] [Abstract][Full Text] [Related]
6. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
7. Acquired hepatocerebral degeneration and hepatic encephalopathy: one or two entities?
Malaquias MJ; Pinto CM; Ramos C; Ferreira S; Gandara J; Almeida A; Cavaco S; Miranda HP; Magalhães M
Eur J Neurol; 2020 Dec; 27(12):2396-2404. PubMed ID: 32810879
[TBL] [Abstract][Full Text] [Related]
8. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease.
Alkhalik Basha MA; Refaat R; Ahmed AF; Yousef HY; Alsowey AM; Metwally MI; Aly SA; Hussien HM; El-Saadany HF; AlGhobashy AA; Talat MA; Amer MM; Eid AM
Eur J Radiol; 2019 Feb; 111():41-46. PubMed ID: 30691663
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
10. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
[TBL] [Abstract][Full Text] [Related]
11. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
12. Childhood Wilson Disease: Bangladesh Perspective.
Rukunuzzaman M; Karim AB; Nurullah M; Sultana F; Mazumder MW; Rahman MA; Billah SB; Begum F; Oliullah M
Mymensingh Med J; 2017 Apr; 26(2):406-413. PubMed ID: 28588179
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance proton spectroscopy of the brain in Wilson's disease.
Kraft E; Trenkwalder C; Then Bergh F; Auer DP
J Neurol; 1999 Aug; 246(8):693-9. PubMed ID: 10460447
[TBL] [Abstract][Full Text] [Related]
14. Wilson disease.
Kitzberger R; Madl C; Ferenci P
Metab Brain Dis; 2005 Dec; 20(4):295-302. PubMed ID: 16382340
[TBL] [Abstract][Full Text] [Related]
15. Case report: Recurring and treatment-resistant depression in acquired hepatocerebral degeneration due to a congenital portosystemic shunt.
Tamura T; Takagi S; Hayakawa A; Oyama J; Fujino J; Shiwaku H; Takahashi H; Sugihara G
Front Psychiatry; 2024; 15():1402695. PubMed ID: 38716114
[TBL] [Abstract][Full Text] [Related]
16. Acquired hepatocerebral degeneration (AHD): a peculiar neurological impairment in advanced chronic liver disease.
Pigoni A; Iuculano F; Saetti C; Airaghi L; Burdick L; Spreafico S; Curioni M; Lombardi R; Valenti L; Fracanzani AL; Fargion S
Metab Brain Dis; 2018 Feb; 33(1):347-352. PubMed ID: 28918510
[TBL] [Abstract][Full Text] [Related]
17. Hepatic features of Wilson disease.
Boga S; Ala A; Schilsky ML
Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
[TBL] [Abstract][Full Text] [Related]
18. In vivo proton magnetic resonance spectroscopy for the evaluation of hepatic encephalopathy in dogs.
Carrera I; Kircher PR; Meier D; Richter H; Beckman K; Dennler M
Am J Vet Res; 2014 Sep; 75(9):818-27. PubMed ID: 25157885
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
Van Den Heuvel AG; Van der Grond J; Van Rooij LG; Van Wassenaer-van Hall HN; Hoogenraad TU; Mali WP
Radiology; 1997 May; 203(2):539-43. PubMed ID: 9114118
[TBL] [Abstract][Full Text] [Related]
20. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
